{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:40:39Z","timestamp":1761824439528,"version":"3.43.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>Diencephalic syndrome is usually associated with tumors in the hypothalamic region, rarely occurring in patients with neurofibromatosis type 1 (NF1)-associated gliomas. We describe the clinical presentation and response to treatment in 3 patients with NF1 presenting with diencephalic syndrome as first symptom of optic pathway\/hypothalamic glioma (OPHG). Because of the rarity of this constellation, knowledge about the clinical course and best treatment options for patients with NF1-associated OPHG and diencephalic syndrome is still limited. All 3 patients showed good response to treatment with normalization of body mass index and decrease in tumor volume within 6 months.<\/jats:p>","DOI":"10.1097\/mph.0000000000002569","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T17:14:59Z","timestamp":1675358099000},"page":"e543-e546","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of NF1-Associated Optic Pathway\/Hypothalamic Gliomas in Patients With Diencephalic Syndrome"],"prefix":"10.1097","volume":"45","author":[{"given":"Annette","family":"Weiser","sequence":"first","affiliation":[{"name":"Division of Oncology and Children\u2019s Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7327-1069","authenticated-orcid":false,"given":"Heinz","family":"Hengartner","sequence":"additional","affiliation":[{"name":"Division of Oncology, Pediatric Hospital of Eastern Switzerland, St. Gallen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0166-2770","authenticated-orcid":false,"given":"Raimund","family":"Kottke","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Imaging"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Grehten","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Imaging"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra P.","family":"Toelle","sequence":"additional","affiliation":[{"name":"Division of Neurology, University Children\u2019s Hospital Zurich, Zurich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-631X","authenticated-orcid":false,"given":"Nicolas U.","family":"Gerber","sequence":"additional","affiliation":[{"name":"Division of Oncology and Children\u2019s Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Grotzer","sequence":"additional","affiliation":[{"name":"Division of Oncology and Children\u2019s Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3136-9241","authenticated-orcid":false,"given":"Ana S.","family":"Guerreiro Stucklin","sequence":"additional","affiliation":[{"name":"Division of Oncology and Children\u2019s Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000369802","article-title":"Endocrine implications of neurofibromatosis 1 in childhood","volume":"83","author":"Bizzarri","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1186\/s12885-015-1626-x","article-title":"An infant with hyperalertness, hyperkinesis, and failure to thrive: a rare diencephalic syndrome due to hypothalamic anaplastic astrocytoma","volume":"15","author":"Stival","year":"2015","journal-title":"BMC Cancer"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"e742","DOI":"10.1542\/peds.2004-2237","article-title":"Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance","volume":"115","author":"Fleischman","year":"2005","journal-title":"Pediatrics"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/diagnostics12030664","article-title":"Diencephalic syndrome due to optic pathway gliomas in pediatric patients: an Italian multicenter study","volume":"12","author":"De Martino","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-013-1284-2","article-title":"Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach","volume":"116","author":"Kilday","year":"2014","journal-title":"J Neurooncol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.critrevonc.2016.05.008","article-title":"Neurofibromatosis type 1 associated low grade gliomas: a comparison with sporadic low grade gliomas","volume":"104","author":"Helfferich","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0883073817739509","article-title":"Optic pathway gliomas in neurofibromatosis type 1","volume":"33","author":"Campen","year":"2018","journal-title":"J Child Neurol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-0035-1570491","article-title":"The changing landscape of pediatric low-grade gliomas: clinical challenges and emerging therapies","volume":"47","author":"Guerreiro Stucklin","year":"2016","journal-title":"Neuropediatrics"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00381-013-2109-5","article-title":"Diencephalic syndrome as sign of tumor progression in a child with neurofibromatosis type 1 and optic pathway glioma: a case report","volume":"29","author":"Cavicchiolo","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"R11-20250804","first-page":"10","article-title":"Diencephalic syndrome in child with NF-1 and hypothalamic tumour","volume":"2","author":"Pilotto","year":"2018","journal-title":"J Neurol Clin Neurosci"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"dgaa138","DOI":"10.1210\/clinem\/dgaa138","article-title":"Pretreatment endocrine disorders due to optic pathway gliomas in pediatric neurofibromatosis type 1: multicenter study","volume":"105","author":"Santoro","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"e27234","DOI":"10.1002\/pbc.27234","article-title":"Single-agent bevacizumab in the treatment of recurrent or refractory pediatric low-grade glioma: a single institutional experience","volume":"65","author":"Gorsi","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cam4.1799","article-title":"Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma","volume":"8","author":"Zhukova","year":"2019","journal-title":"Cancer Med"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2011.34.5843","article-title":"Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma","volume":"30","author":"Bouffet","year":"2012","journal-title":"J Clin Oncol"},{"key":"R16-20250804","first-page":"327","article-title":"[Pilocytic astrocytoma and diencephalic syndrome in an adult with neurofibromatosis type 1]","volume":"43","author":"Kohira","year":"2003","journal-title":"Rinsho Shinkeigaku"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11060-010-0159-z","article-title":"Natural history and management of low-grade glioma in NF-1 children","volume":"100","author":"Hernaiz Driever","year":"2010","journal-title":"J Neurooncol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamaophthalmol.2015.1940","article-title":"Nystagmus in an emaciated infant","volume":"133","author":"Dhannawat","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"e0127676","DOI":"10.1371\/journal.pone.0127676","article-title":"Mortality in children with optic pathway glioma treated with up-front BB-SFOP chemotherapy","volume":"10","author":"Rakotonjanahary","year":"2015","journal-title":"PLoS One"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"e20190660","DOI":"10.1542\/peds.2019-0660","article-title":"Health supervision for children with neurofibromatosis type 1","volume":"143","author":"Miller","year":"2019","journal-title":"Pediatrics"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:08:52Z","timestamp":1754338132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002569","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"2022-07-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}